Please ensure Javascript is enabled for purposes of website accessibility

Here's Why Qiagen Jumped Higher Today

By Brian Orelli, PhD - Mar 3, 2020 at 2:23PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The diagnostic-test maker is being acquired for $11.5 billion.

What happened

Shares of Qiagen (QGEN 3.86%) were up 14.7% at 1:45 p.m. EST on Tuesday because the company is being acquired by Thermo Fisher Scientific (TMO 5.97%) in an all-cash deal that values Qiagen at $11.5 billion.

So what

The news comes as a bit of a surprise since Thermo Fisher and others had been rumored to be in talks with Qiagen in November (which was eventually confirmed by management). But a month later, Qiagen management decided that none of the deals were a better option for shareholders than remaining a stand-alone company.

Healthcare investors will have to wait for documents to be filed with the Securities and Exchange Commission to get the backstory on how the deal went down, but presumably Thermo Fisher sweetened its offer to get Qiagen to come to the table.

A handshake

Image source: Getty Images.

Thermo Fisher will pay 39 euros per share for stock that trades on the Frankfurt Prime Standard, which is about $43.55 at current exchange rates, for shares that trade on the NYSE. Thermo Fisher expects the purchase to be immediately accretive to its adjusted earnings per share and thinks it can realize $200 million in synergies over the three years after the deal closes.

Through the acquisition, Thermo Fisher gets a wide array of products that are used in scientific and clinical labs for doing experiments and testing patient samples. The deal allows Thermo Fisher to expand its DNA sequencing business (Qiagen recently signed a deal with Illumina), and the company also gains access to Qiagen's new coronavirus test that began shipping last month.

Now what

With shares trading below the eventual buyout price, it appears investors have decided that another company isn't likely to outbid Thermo Fisher. The deal is expected to close in the first half of 2021.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

QIAGEN N.V. Stock Quote
$47.39 (3.86%) $1.76
Thermo Fisher Scientific Inc. Stock Quote
Thermo Fisher Scientific Inc.
$572.35 (5.97%) $32.24

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/28/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.